|
1
|
Zimmermann TS, Lee AC, Akinc A, Bramlage
B, Bumcrot D, Fedoruk MN, Harborth J, Heyes JA, Jeffs LB, John M,
et al: RNAi-mediated gene silencing in non-human primates. Nature.
441:111–114. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wang J, Lu Z, Wientjes MG and Au JLS:
Delivery of siRNA therapeutics: Barriers and carriers. AAPS J.
12:492–503. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Barba AA, Cascone S, Caccavo D, Lamberti
G, Chiarappa G, Abrami M, Grassi G, Grassi M, Tomaiuolo G, Guido S,
et al: Engineering approaches in siRNA delivery. Int J Pharm.
525:343–358. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Khalil IA, Yamada Y and Harashima H:
Optimization of siRNA delivery to target sites: Issues and future
directions. Expert Opin Drug Deliv. 15:1053–1065. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yan Y, Liu XY, Lu A, Wang XY, Jiang LX and
Wang JC: Non-viral vectors for RNA delivery. J Control Release.
342:241–279. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhang Y, Satterlee A and Huang L: In vivo
gene delivery by nonviral vectors: Overcoming hurdles? Mol Ther.
20:1298–1304. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Xue HY, Guo P, Wen WC and Wong HL:
Lipid-based nanocarriers for RNA delivery. Curr Pharm Des.
21:3140–3147. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hattori Y, Tamaki K, Ozaki KI, Kawano K
and Onishi H: Optimized combination of cationic lipids and neutral
helper lipids in cationic liposomes for siRNA delivery into the
lung by intravenous injection of siRNA lipoplexes. J Drug Deliv Sci
Technol. 52:1042–1050. 2019. View Article : Google Scholar
|
|
9
|
Hattori Y, Tang M, Torii S, Tomita K,
Sagawa A, Inoue N, Yamagishi R and Ozaki KI: Optimal combination of
cationic lipid and phospholipid in cationic liposomes for gene
knockdown in breast cancer cells and mouse lung using siRNA
lipoplexes. Mol Med Rep. 26:2532022. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Xia Y, Tian J and Chen X: Effect of
surface properties on liposomal siRNA delivery. Biomaterials.
79:56–68. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hattori Y, Nakamura M, Takeuchi N, Tamaki
K, Shimizu S, Yoshiike Y, Taguchi M, Ohno H, Ozaki KI and Onishi H:
Effect of cationic lipid in cationic liposomes on siRNA delivery
into the lung by intravenous injection of cationic lipoplex. J Drug
Target. 27:217–227. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yamato K, Yamada T, Kizaki M, Ui-Tei K,
Natori Y, Fujino M, Nishihara T, Ikeda Y, Nasu Y, Saigo K and
Yoshinouchi M: New highly potent and specific E6 and E7 siRNAs for
treatment of HPV16 positive cervical cancer. Cancer Gene Ther.
15:140–153. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hattori Y, Tamaki K, Sakasai S, Ozaki KI
and Onishi H: Effects of PEG anchors in PEGylated siRNA lipoplexes
on in vitro gene-silencing effects and siRNA biodistribution
in mice. Mol Med Rep. 22:4183–4196. 2020.PubMed/NCBI
|
|
14
|
Tang M, Sakasai S, Onishi H, Kawano K and
Hattori Y: Effect of PEG anchor in PEGylation of folate-modified
cationic liposomes with PEG-derivatives on systemic siRNA delivery
into the tumor. J Drug Target. 31:74–88. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Suzuki A, Hamada K, Sasaki T, Mak TW and
Nakano T: Role of PTEN/PI3K pathway in endothelial cells. Biochem
Soc Trans. 35:172–176. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Dumont DJ, Gradwohl GJ, Fong GH, Auerbach
R and Breitman ML: The endothelial-specific receptor tyrosine
kinase, tek, is a member of a new subfamily of receptors. Oncogene.
8:1293–1301. 1993.PubMed/NCBI
|
|
17
|
Fehring V, Schaeper U, Ahrens K, Santel A,
Keil O, Eisermann M, Giese K and Kaufmann J: Delivery of
therapeutic siRNA to the lung endothelium via novel lipoplex
formulation DACC. Mol Ther. 22:811–820. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Gutbier B, Kube SM, Reppe K, Santel A,
Lange C, Kaufmann J, Suttorp N and Witzenrath M: RNAi-mediated
suppression of constitutive pulmonary gene expression by small
interfering RNA in mice. Pulm Pharmacol Ther. 23:334–344. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Cheng X and Lee RJ: The role of helper
lipids in lipid nanoparticles (LNPs) designed for oligonucleotide
delivery. Adv Drug Deliv Rev. 99:129–137. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Paliwal SR, Paliwal R and Vyas SP: A
review of mechanistic insight and application of pH-sensitive
liposomes in drug delivery. Drug Deliv. 22:231–242. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sun D and Lu ZR: Structure and function of
cationic and ionizable lipids for nucleic acid delivery. Pharm Res.
40:27–46. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chen H, Ren X, Xu S, Zhang D and Han T:
Optimization of lipid nanoformulations for effective mRNA delivery.
Int J Nanomedicine. 17:2893–2905. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Eliyahu H, Servel N, Domb AJ and Barenholz
Y: Lipoplex-induced hemagglutination: Potential involvement in
intravenous gene delivery. Gene Ther. 9:850–858. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hattori Y, Nakamura A, Hanaya S, Miyanabe
Y, Yoshiike Y, Kikuchi T, Ozaki K and Onishi H: Effect of
chondroitin sulfate on siRNA biodistribution and gene silencing
effect in mice after injection of siRNA lipoplexes. J Drug Deliv
Sci Technol. 41:401–409. 2017. View Article : Google Scholar
|
|
26
|
Thi TTH, Suys EJA, Lee JS, Nguyen DH, Park
KD and Truong NP: Lipid-based nanoparticles in the clinic and
clinical trials: From cancer nanomedicine to COVID-19 vaccines.
Vaccines (Basel). 9:3592021. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Dilliard SA, Cheng Q and Siegwart DJ: On
the mechanism of tissue-specific mRNA delivery by selective organ
targeting nanoparticles. Proc Natl Acad Sci USA.
118:e21092561182021. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Funakoshi Y, Iwao Y, Noguchi S and Itai S:
Effect of alkyl chain length and unsaturation of the phospholipid
on the physicochemical properties of lipid nanoparticles. Chem
Pharm Bull (Tokyo). 63:731–736. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Tagami T, Hirose K, Barichello JM, Ishida
T and Kiwada H: Global gene expression profiling in cultured cells
is strongly influenced by treatment with siRNA-cationic liposome
complexes. Pharm Res. 25:2497–2504. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ma Z, Li J, He F, Wilson A, Pitt B and Li
S: Cationic lipids enhance siRNA-mediated interferon response in
mice. Biochem Biophys Res Commun. 330:755–759. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Willam C, Koehne P, Jürgensen JS, Gräfe M,
Wagner KD, Bachmann S, Frei U and Eckardt KU: Tie2 receptor
expression is stimulated by hypoxia and proinflammatory cytokines
in human endothelial cells. Circ Res. 87:370–377. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Rajesh M, Sen J, Srujan M, Mukherjee K,
Sreedhar B and Chaudhuri A: Dramatic influence of the orientation
of linker between hydrophilic and hydrophobic lipid moiety in
liposomal gene delivery. J Am Chem Soc. 129:11408–11420. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Srujan M, Chandrashekhar V, Reddy RC,
Prabhakar R, Sreedhar B and Chaudhuri A: The influence of the
structural orientation of amide linkers on the serum compatibility
and lung transfection properties of cationic amphiphiles.
Biomaterials. 32:5231–5240. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhi D, Bai Y, Yang J, Cui S, Zhao Y, Chen
H and Zhang S: A review on cationic lipids with different linkers
for gene delivery. Adv Colloid Interface Sci. 253:117–140. 2018.
View Article : Google Scholar : PubMed/NCBI
|
